We are live on
!
Find out more
RT
Robert Torray Torray Investment Partners
AUM
$741M
1-Year Est. Return
26.16%
Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$459M
AUM Growth
–
Cap. Flow
+$456M
Cap. Flow
% of AUM
99.34%
Top 10 Holdings %
Top 10 Hldgs %
30.85%
Holding
73
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$16.7M |
| 2 |
TUP
Tupperware Brands Corporation
TUP
|
+$16.3M |
| 3 |
Wells Fargo
WFC
|
+$14.9M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$14.7M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.57% |
| 2 | Financials | 18.9% |
| 3 | Technology | 18.59% |
| 4 | Industrials | 15.98% |
| 5 | Materials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cognizant
CTSH
$27.9B
| $9.11M | 1.98% |
+291,000
| New | +$9.67M |
|
|
CHK
27
DELISTED
Chesapeake Energy Corporation
CHK
| $8.7M | 1.89% |
+2,256
| New | +$8.66M |
|
28
DuPont de Nemours
DD
$18.7B
| $8.62M | 1.88% |
+105,749
| New | +$8.92M |
|
29
HP
HPQ
$27.2B
| $8.14M | 1.77% |
+723,137
| New | +$7.38M |
|
30
AT&T
T
$173B
| $8.04M | 1.75% |
+300,813
| New | +$8.36M |
|
31
Danaher
DHR
$154B
| $4.7M | 1.02% |
+110,442
| New | +$4.57M |
|
32
EOG Resources
EOG
$80.3B
| $4.64M | 1.01% |
+70,468
| New | +$4.52M |
|
33
Qualcomm
QCOM
$169B
| $4.6M | 1% |
+75,357
| New | +$4.81M |
|
34
Visa
V
$693B
| $4.5M | 0.98% |
+98,416
| New | +$4.31M |
|
35
Apple
AAPL
$4.51T
| $4.41M | 0.96% |
+311,304
| New | +$4.79M |
|
|
PCP
36
DELISTED
PRECISION CASTPARTS CORP
PCP
| $4.33M | 0.94% |
+19,155
| New | +$3.88M |
|
37
Enbridge
ENB
$110B
| $4.31M | 0.94% |
+102,490
| New | +$4.62M |
|
38
American Tower
AMT
$81.9B
| $4.26M | 0.93% |
+58,187
| New | +$4.63M |
|
39
RTX Corp
RTX
$283B
| $4.06M | 0.88% |
+69,403
| New | +$4.1M |
|
|
FISV
40
Fiserv Inc
FISV
$28B
| $3.98M | 0.87% |
+182,080
| New | +$3.99M |
|
41
Gilead Sciences
GILD
$181B
| $3.85M | 0.84% |
+75,143
| New | +$3.92M |
|
42
Colgate-Palmolive
CL
$72.6B
| $3.81M | 0.83% |
+66,443
| New | +$3.94M |
|
43
Amphenol
APH
$194B
| $3.73M | 0.81% |
+382,416
| New | +$3.66M |
|
44
Accenture
ACN
$113B
| $3.69M | 0.8% |
+51,308
| New | +$4.08M |
|
45
Nike
NKE
$60.5B
| $3.64M | 0.79% |
+114,250
| New | +$3.55M |
|
46
Vertex Pharmaceuticals
VRTX
$139B
| $3.63M | 0.79% |
+45,372
| New | +$3.34M |
|
47
Franklin Templeton, Inc.
BEN
$17.4B
| $3.45M | 0.75% |
+76,155
| New | +$3.88M |
|
|
PX
48
DELISTED
Praxair Inc
PX
| $3.23M | 0.7% |
+28,002
| New | +$3.19M |
|
49
Tapestry
TPR
$26B
| $3.22M | 0.7% |
+56,367
| New | +$3.17M |
|
50
Compass Minerals
CMP
$1.09B
| $3.16M | 0.69% |
+37,339
| New | +$3.15M |
|
Similar funds
LGA
SIC
CPC
NC
TWM
WIC
NCA
TPM
Robert Torray's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Robert Torray, which disclosed 73 positions worth $459M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is Baxter International: 436,195 shares worth $16.4M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, followed by Financials and Technology.
- Robert Torray's largest Q2 2013 buy was Baxter International: 436,195 shares worth $16.4M.
- Robert Torray's ten largest holdings make up 31% of its $459M portfolio in Q2 2013.
- Robert Torray disclosed 73 positions in Q2 2013, its first 13F filing on record.
Based on Torray Investment Partners's 13F filing for Q2 2013, filed 13 Aug 2013.